Delek US (DK) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Morgan Stanley Maintains Delek US(DK.US) With Sell Rating, Cuts Target Price to $19
Moomoo NewsJan 14 09:31 ET · Ratings
Here're Heartland Value Fund's Views on Delek US Holdings (DK)
Yahoo FinanceJan 14 08:25 ET
Wells Fargo Maintains Delek US(DK.US) With Sell Rating, Raises Target Price to $17
Moomoo NewsJan 13 20:31 ET · Ratings
Challenging Quarter for Delek US Holdings Amid Declining Crack Spreads and Strategic Mitigation Efforts
TipRanksJan 13 01:26 ET
BofA Securities Maintains Delek US(DK.US) With Sell Rating, Cuts Target Price to $14
Moomoo NewsJan 10 07:31 ET · Ratings
Bank of America Securities Sticks to Its Sell Rating for Delek US Holdings (DK)
TipRanksJan 10 06:39 ET · Ratings

Comments

Moomoo AI

Feb 23, 2024 09:14

Delek US Holdings' low P/S ratio is due to predicted revenue decline. Investors see no significant potential for revenue growth to justify a higher P/S ratio. Without major changes, a significant stock price increase is unlikely. The company's weak outlook is pressuring the shares downwards.

Benign Growth For Delek US Holdings, Inc. (NYSE:DK) Underpins Its Share Price

Moomoo AI

Jan 18, 2024 15:56

The board of Delek US Holdings expresses positive sentiment towards the appointment of Ms. Benson, highlighting her experience in risk management, capital markets, and green energies as instrumental for the company's strategic initiatives.

Press Release: Delek US Holdings Board Appoints New Director

Moomoo AI

Nov 15, 2023 06:51

Delek's lower Return on Equity (ROE) coupled with high debt levels make it less attractive for investment. Investors should also consider profit growth rates and market expectations before investing in Delek or similar companies.

Should We Be Cautious About Delek US Holdings, Inc.'s (NYSE:DK) ROE Of 8.4%?

Moomoo Breakfast US

Jun 22, 2022 07:48

Columns Today's pre-market stock movers: BBIO, LZB, ORA, DOW and more

Gainers:
• $La-Z-Boy (LZB.US)$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals (ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer (PFE.US)$)
• $Ikena Oncology (IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma (BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech (KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-V...

8

1

3

william browning

Apr 1, 2021 15:19

slow but steady stock

$Delek US (DK.US)$

DK Delek US

Trade Overview

Capital Trend

News

Comments

Trending Stocks